AAAAAA
Results:
1-12
|
Results: 12
Authors:
Grimm, PD
Blasko, JC
Sylvester, JE
Meier, RM
Cavanagh, W
Citation: Pd. Grimm et al., 10-year biochemical (prostate-specific antigen) control of prostate cancerwith I-125 brachytherapy, INT J RAD O, 51(1), 2001, pp. 31-40
Authors:
Lederman, GS
Cavanagh, W
Albert, PS
Israeli, R
Lessing, J
Savino, M
Volpicella, F
Citation: Gs. Lederman et al., Retrospective stratification of a consecutive cohort of prostate cancer patients treated with a combined regimen of external-beam radiotherapy and brachytherapy, INT J RAD O, 49(5), 2001, pp. 1297-1303
Authors:
Kattan, MW
Potters, L
Blasko, JC
Beyer, DC
Fearn, P
Cavanagh, W
Leibel, S
Scardino, PT
Citation: Mw. Kattan et al., Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer, UROLOGY, 58(3), 2001, pp. 393-399
Authors:
Sylvester, J
Grimm, P
Blasko, J
Meier, R
Spiegel, J
Heaney, C
Cavanagh, W
Citation: J. Sylvester et al., The role of androgen ablation in patients with biochemical or local failure after definitive radiation therapy: A survey of practice patterns of urologists and radiation oncologists in the United States, UROLOGY, 58(2A), 2001, pp. 65-70
Authors:
Sylvester, J
Blasko, JC
Grimm, PD
Meier, R
Cavanagh, W
Citation: J. Sylvester et al., Short-course androgen ablation combined with external-beam radiation therapy and low-dose-rate permanent brachytherapy in early-stage prostate cancer: A matched subset analysis, MOL UROL, 4(3), 2000, pp. 155-159
Authors:
Blasko, JC
Grimm, PD
Sylvester, JE
Cavanagh, W
Citation: Jc. Blasko et al., Regarding Blasko et al. Pallidium-103 brachytherapy for prostate carcinoma. IJROBP 2000;46 : 839-850 - Response, INT J RAD O, 48(4), 2000, pp. 1267-1267
Authors:
Blasko, JC
Grimm, PD
Sylvester, JE
Badiozamani, KR
Hoak, D
Cavanagh, W
Citation: Jc. Blasko et al., Palladium-103 brachytherapy for prostate carcinoma, INT J RAD O, 46(4), 2000, pp. 839-850
Authors:
Blasko, JC
Grimm, PD
Sylsvester, JE
Cavanagh, W
Citation: Jc. Blasko et al., The role of external beam radiotherapy with I-125/Pd-103 brachytherapy forprostate carcinoma, RADIOTH ONC, 57(3), 2000, pp. 273-278
Authors:
Sylvester, J
Blasko, JC
Grimm, PD
Meier, R
Goy, B
Colburn, G
Cavanagh, W
Citation: J. Sylvester et al., Neoadjuvant androgen ablation combined with external-beam radiation therapy and permanent interstitial brachytherapy boost in localized prostate cancer, MOL UROL, 3(3), 1999, pp. 231-236
Authors:
Bellon, J
Wallner, K
Ellis, W
Russell, K
Cavanagh, W
Blasko, J
Citation: J. Bellon et al., Use of pelvic CT scanning to evaluate pubic arch interference of transperineal prostate brachytherapy, INT J RAD O, 43(3), 1999, pp. 579-581
Authors:
Wallner, K
Ellis, W
Russell, K
Cavanagh, W
Blasko, J
Citation: K. Wallner et al., Use of TRUS to predict pubic arch interference of prostate brachytherapy, INT J RAD O, 43(3), 1999, pp. 583-585
Authors:
Badiozamani, KR
Wallner, K
Cavanagh, W
Blasko, J
Citation: Kr. Badiozamani et al., Comparability of CT-based and TRUS-based prostate volumes, INT J RAD O, 43(2), 1999, pp. 375-378
Risultati:
1-12
|